Moderna completes enrollment for phase 2 trial of mRNA-1273
Moderna said that it has concluded enrollment for the two cohorts of the phase 2 study of its COVID-19 vaccine candidate mRNA-1273. According to the ... Read More
Coronavirus vaccine trial results : Moderna mRNA-1273 shows early promise
Moderna said that mRNA-1273, its novel coronavirus vaccine candidate, has delivered positive interim data in a phase 1 clinical trial by eliciting neutralizing antibody titer ... Read More
Coronavirus vaccine trial : Moderna doses first subject with mRNA-1273 in phase 1 trial
Coronavirus vaccine trial : US biotech company Moderna has dosed the first participant in the phase 1 study of mRNA-1273, its mRNA vaccine against the ... Read More